Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giardiello

Showing results (261-270 of 342) with videos related to

Pageof 35
Sort By:
Scientific Reports|September 22, 2017
Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patientsHuiying Ma, Lodewijk A A Brosens, Sjoerd G Elias, et al.
Stem Cells (Dayton, Ohio)|June 15, 2016
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating CellsAlessandra Tuccitto, Marcella Tazzari, Valeria Beretta, et al.
Familial Cancer|December 23, 2015
Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposisNicolás Casellas-Cabrera, Yaritza Díaz-Algorri, Víctor J Carlo-Chévere, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2004
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approachMarcia Irene Canto, Michael Goggins, Charles J Yeo, et al.
Obesity Surgery|October 2, 2025
Multicenter Retrospective Analysis of Consecutive Swallowable Gastric Balloon Treatments in a Community Obesity Care SettingAdelardo Caballero, Cristiano Giardiello, Giovanni Quartararo, et al.
The New England Journal of Medicine|April 5, 2002
Primary chemoprevention of familial adenomatous polyposis with sulindacFrancis M Giardiello, Vincent W Yang, Linda M Hylind, et al.
Annals of Surgical Oncology|November 6, 2002
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposisM G Sayed, A F Ahmed, J R Ringold, et al.
The Lancet. Healthy Longevity|September 13, 2022
Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based studyWilleke G van der Plas-Krijgsman, Daniele Giardiello, Hein Putter, et al.
CA: a Cancer Journal for Clinicians|March 7, 2008
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyBernard Levin, David A Lieberman, Beth McFarland, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patientsJan J Koornstra, Fleur E M Rijcken, Corina N A M Oldenhuis, et al.
Pageof 35

Showing results (261-270 of 342) with videos related to

Sort By:
Pageof 35
Scientific Reports|September 22, 2017
Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patientsHuiying Ma, Lodewijk A A Brosens, Sjoerd G Elias, et al.
Stem Cells (Dayton, Ohio)|June 15, 2016
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating CellsAlessandra Tuccitto, Marcella Tazzari, Valeria Beretta, et al.
Familial Cancer|December 23, 2015
Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposisNicolás Casellas-Cabrera, Yaritza Díaz-Algorri, Víctor J Carlo-Chévere, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2004
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approachMarcia Irene Canto, Michael Goggins, Charles J Yeo, et al.
Obesity Surgery|October 2, 2025
Multicenter Retrospective Analysis of Consecutive Swallowable Gastric Balloon Treatments in a Community Obesity Care SettingAdelardo Caballero, Cristiano Giardiello, Giovanni Quartararo, et al.
The New England Journal of Medicine|April 5, 2002
Primary chemoprevention of familial adenomatous polyposis with sulindacFrancis M Giardiello, Vincent W Yang, Linda M Hylind, et al.
Annals of Surgical Oncology|November 6, 2002
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposisM G Sayed, A F Ahmed, J R Ringold, et al.
The Lancet. Healthy Longevity|September 13, 2022
Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based studyWilleke G van der Plas-Krijgsman, Daniele Giardiello, Hein Putter, et al.
CA: a Cancer Journal for Clinicians|March 7, 2008
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyBernard Levin, David A Lieberman, Beth McFarland, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patientsJan J Koornstra, Fleur E M Rijcken, Corina N A M Oldenhuis, et al.
Pageof 35